Related references
Note: Only part of the references are listed.Efficacy of the bivalent HPV vaccine against HPV 16/18-associated precancer: long-term follow-up results from the Costa Rica Vaccine Trial
Carolina Porras et al.
LANCET ONCOLOGY (2020)
Development of the TypeSeq Assay for Detection of 51 Human Papillomavirus Genotypes by Next-Generation Sequencing
Sarah Wagner et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2019)
Evaluation of TypeSeq, a Novel High-Throughput, Low-Cost, Next-Generation Sequencing-Based Assay for Detection of 51 Human Papillomavirus Genotypes
Sarah Wagner et al.
JOURNAL OF INFECTIOUS DISEASES (2019)
Is the risk of cervical atypia associated with the interval between menarche and the start of sexual activity? A population-based cohort study
Indira Adhikari et al.
BMJ OPEN (2019)
Prevalence and Incidence of Human Papillomavirus (HPV) Infection Before and After Pregnancy: Pooled Analysis of the Control Arms of Efficacy Trials of HPV-16/18 AS04-Adjuvanted Vaccine
Jing Chen et al.
OPEN FORUM INFECTIOUS DISEASES (2019)
The natural history of human papillomavirus infection
Silvia de Sanjose et al.
BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY (2018)
Human papillomavirus vaccination and the role of herd effects in future cancer control planning: a review
Talia Malagon et al.
EXPERT REVIEW OF VACCINES (2018)
HPV vaccines - A review of the first decade
Diane M. Harper et al.
GYNECOLOGIC ONCOLOGY (2017)
Is oral contraceptive use associated with an increased risk of cervical cancer? An evidence-based meta-analysis
Yunhua Peng et al.
JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (2017)
Lifetime cancer risk and combined oral contraceptives: the Royal College of General Practitioners' Oral Contraception Study
Lisa Iversen et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2017)
Factors associated with type-specific persistence of high-risk human papillomavirus infection: A population-based study
Signe Stensen et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Incidence and duration of type-specific human papillomavirus infection in high-risk HPV-naive women: results from the control arm of a phase II HPV-16/18 vaccine trial
Agnihotram V. Ramanakumar et al.
BMJ OPEN (2016)
The Influence of Hormonal Factors on the Risk of Developing Cervical Cancer and Pre-Cancer: Results from the EPIC Cohort
Esther Roura et al.
PLOS ONE (2016)
Rationale and design of a long term follow-up study of women who did and did not receive HPV 16/18 vaccination in Guanacaste, Costa Rica
Paula Gonzalez et al.
VACCINE (2015)
Parity as a cofactor for high-grade cervical disease among women with persistent human papillomavirus infection: a 13-year follow-up
K. E. Jensen et al.
BRITISH JOURNAL OF CANCER (2013)
Type-specific persistence and associated risk factors of human papillomavirus infections in women living in central Italy
Michela L. Sammarco et al.
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2013)
The role of co-factors in the progression from human papillomavirus infection to cervical cancer
Patricia Luhn et al.
GYNECOLOGIC ONCOLOGY (2013)
HPV16 is associated with younger age in women with cervical intraepithelial neoplasia grade 2 and 3
L. Baandrup et al.
GYNECOLOGIC ONCOLOGY (2012)
Injectable and Oral Contraceptive Use and Cancers of the Breast, Cervix, Ovary, and Endometrium in Black South African Women: Case-Control Study
Margaret Urban et al.
PLOS MEDICINE (2012)
Hormonal Contraceptives and the Length of Their Use Are Not Independent Risk Factors for High-Risk HPV Infections or High-Grade CIN
Adhemar Longatto-Filho et al.
GYNECOLOGIC AND OBSTETRIC INVESTIGATION (2011)
Age distribution of HPV genotypes in cervical intraepithelial neoplasia
Mario Sideri et al.
GYNECOLOGIC ONCOLOGY (2011)
Smoking habit, immune suppression, oral contraceptive use, and hormone replacement therapy use and cervical carcinogenesis: a review of the literature
Angiolo Gadducci et al.
GYNECOLOGICAL ENDOCRINOLOGY (2011)
Co-factors of high-risk human papillomavirus infections display unique profiles in incident CIN1, CIN2 and CIN3
K. Syrjanen et al.
INTERNATIONAL JOURNAL OF STD & AIDS (2011)
Intrauterine device use, cervical infection with human papillomavirus, and risk of cervical cancer: a pooled analysis of 26 epidemiological studies
Xavier Castellsague et al.
LANCET ONCOLOGY (2011)
Human Papillomavirus Genotypes in Cervical Intraepithelial Neoplasia Grade 3
Philip E. Castle et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)
Marginal and Mixed-Effects Models in the Analysis of Human Papillomavirus Natural History Data
Xiaonan Xue et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)
Estrogen and ERα: Culprits in cervical cancer?
Sang-Hyuk Chung et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2010)
Cervical Carcinoma and Sexual Behavior: Collaborative Reanalysis of Individual Data on 15,461 Women with Cervical Carcinoma and 29,164 Women without Cervical Carcinoma from 21 Epidemiological Studies
Paul Appleby et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2009)
Human Papillomavirus Genotype Distributions: Implications for Vaccination and Cancer Screening in the United States
Cosette M. Wheeler et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Cervical Human Papillomavirus Incidence and Persistence in a Cohort of HIV-Negative Women in Zimbabwe
Emily Fukuchi et al.
SEXUALLY TRANSMITTED DISEASES (2009)
Rationale and design of a community-based double-blind randomized clinical trial of an HPV 16 and 18 vaccine in Guanacaste, Costa Rica
Rolando Herrero et al.
VACCINE (2008)
Members of the human papillornavirus type 18 family (alpha-7 species) share a common association with adenocarcinoma of the cervix
Gary Clifford et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Cervical cancer and hormonal contraceptives:: Collaborative reanalysis of individual data for 16 573 women with cervical cancer and 35 509 women without cervical cancer from 24 epidemiological studies
Paul Appleby et al.
LANCET (2007)
Comparison of risk factors for invasive squamous cell carcinoma and adenocarcinoma of the cervix:: Collaborative reanalysis of individual data on 8,097 women with squamous cell carcinoma and 1,374 women with adenocarcinoma from 12 epidemiological studies
Amy Berrington de Gonzalez et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Reproductive factors, oral contraceptive use, and human papillomavirus infection:: Pooled analysis of the IARC HPV prevalence surveys
Salvatore Vaccarella et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2006)
Cervical carcinoma and reproductive factors:: Collaborative reanalysis of individual data on 16,563 women with cervical carcinoma and 33,542 women without cervical carcinoma from 25 epidemiological studies
P. Appleby et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Highly effective detection of human papillomavirus 16 and 18 DNA by a testing algorithm combining broad-spectrum and type-specific PCR
Leen-Jan van Doorn et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2006)
Cervical cancer and use of hormonal contraceptives: a systematic review
JS Smith et al.
LANCET (2003)
The interval between menarche and age of first sexual intercourse as a risk factor for subsequent HPV infection in adolescent and young adult women
JA Kahn et al.
JOURNAL OF PEDIATRICS (2002)
Share Paper
